ClinicalTrials.Veeva

Find clinical trials for Endometrial Cancer in Aurora, CO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near Aurora, CO, USA:

Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer

This study seeks to determine the effectiveness of Rucaparib as maintenance therapy for metastatic and recurrent endometrial cancer...

Active, not recruiting
Metastatic Endometrial Cancer
Drug: Placebo Oral Tablet
Drug: Rucaparib

Phase 2

University of Colorado Denver (CU Denver)
University of Colorado Denver (CU Denver)

Aurora, Colorado, United States

Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of RGX-104, an oral small molecule targeting the liver X receptor...

Enrolling
Endometrial Cancer
Lung Cancer
Drug: Docetaxel
Drug: Carboplatin

Phase 1

Inspirna

Aurora, Colorado, United States and 20 other locations

IMGN151-1001 is a Phase 1, first in human, open-label dose-escalation and expansion study in adult patients with recurrent endometrial cancer...

Enrolling
Endometrial Cancer
Fallopian Tube Cancer
Drug: IMGN151

Phase 1

ImmunoGen
ImmunoGen

Aurora, Colorado, United States and 5 other locations

Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-002 given intravenously every 3 weeks.

Enrolling
Endometrial Cancer
Ovary Cancer
Drug: STRO-002

Phase 1

Sutro Biopharma

Aurora, Colorado, United States and 26 other locations

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Biological: durvalumab
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

Aurora, Colorado, United States and 202 other locations

compared to Tamoxifen and Medroxyprogesterone acetate in treating endometrial cancer and to determine the types and severity of sid...

Active, not recruiting
Advanced, Persistent, or Recurrent Endometrial Cancer
Drug: Medroxyprogesterone Acetate
Drug: Tamoxifen

Phase 2

GOG Foundation

Aurora, Colorado, United States and 25 other locations

Phase.Cohort A: Advanced or Metastatic Triple Negative Breast Cancer (TNBC) (IO-treated)Cohort B: Advanced or Metastatic Triple Negative Bre ...

Active, not recruiting
Endometrial Cancer
Triple Negative Breast Cancer
Drug: Fruquintinib
Drug: Tislelizumab

Phase 1, Phase 2

HUTCHMED
HUTCHMED

Aurora, Colorado, United States and 15 other locations

This is an open-label, non-randomized, Phase 1b/2 study to determine the safety and tolerability of NC410 when combined with a standard dose of pembr...

Enrolling
Esophageal Cancer
Colo-rectal Cancer
Drug: pembrolizumab
Drug: NC410

Phase 1, Phase 2

NextCure

Aurora, Colorado, United States and 14 other locations

preliminary antitumor activity of NKT3447 in adult subjects with cyclin E1 (CCNE1) amplified ovarian cancer at the RDEs selected in Dose Es...

Enrolling
Platinum-resistant Ovarian Cancer
Endometrial Cancer
Drug: NKT3447

Phase 1

NiKang Therapeutics

Denver, Colorado, United States and 4 other locations

This study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) profile...

Enrolling
Endometrial Cancer
Advanced Cancer
Drug: Balstilimab
Drug: Botensilimab

Phase 1

Agenus
Agenus

Aurora, Colorado, United States and 18 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems